Cite
Safety and tolerability of rapid dose-titration of subcutaneous (SC) treprostinil in pulmonary arterial hypertension (PAH)
MLA
Gruenig, Ekkehard, et al. Safety and Tolerability of Rapid Dose-Titration of Subcutaneous (SC) Treprostinil in Pulmonary Arterial Hypertension (PAH). 2015. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1247371299&authtype=sso&custid=ns315887.
APA
Gruenig, E., Egenlauf, B., Lange, T. J., Krueger, U., Grover, R., Pernow, M., Traube, A., Viethen, T., & Rosenkranz, S. (2015). Safety and tolerability of rapid dose-titration of subcutaneous (SC) treprostinil in pulmonary arterial hypertension (PAH).
Chicago
Gruenig, Ekkehard, Benjamin Egenlauf, Tobias J. Lange, Ulrich Krueger, Rob Grover, Michelle Pernow, Andrew Traube, Thomas Viethen, and Stephan Rosenkranz. 2015. “Safety and Tolerability of Rapid Dose-Titration of Subcutaneous (SC) Treprostinil in Pulmonary Arterial Hypertension (PAH).” http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1247371299&authtype=sso&custid=ns315887.